Skip to search formSkip to main contentSkip to account menu

SB-239063AN

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
p38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1
Abstract The assessment of target organ damage is important in defining the optimal treatment of hypertension and blood pressure… 
2005
2005
Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection.
Highly Cited
2003
Highly Cited
2003
p38 MAPK Inhibitors Ameliorate Target Organ Damage in Hypertension: Part 1. p38 MAPK-Dependent Endothelial Dysfunction and Hypertension
Numerous mediators, believed to play a role in endothelial dysfunction (e.g., neurohormones, cytokines, hypoxia, and stretch… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)